Cowen analyst Yaron Werber weighed in on Acceleron Pharma (NASDAQ: XLRN) following reports the company is in advanced talks to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE